These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 17726343

  • 21. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.
    Herbert C, Hettiaratchi A, Webb DC, Thomas PS, Foster PS, Kumar RK.
    Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529
    [Abstract] [Full Text] [Related]

  • 22. Pregabalin inhibits accelerated defecation and decreased colonic nociceptive threshold in sensitized rats.
    Ohashi-Doi K, Gale JD, Kurebayashi Y.
    Eur J Pharmacol; 2010 Sep 15; 643(1):107-12. PubMed ID: 20598680
    [Abstract] [Full Text] [Related]

  • 23. Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.
    Louw C, Williams Z, Venter L, Leichtl S, Schmid-Wirlitsch C, Bredenbroker D, Bardin PG.
    Respiration; 2007 Sep 15; 74(4):411-7. PubMed ID: 16954654
    [Abstract] [Full Text] [Related]

  • 24. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis.
    Moore CS, Earl N, Frenette R, Styhler A, Mancini JA, Nicholson DW, Hebb AL, Owens T, Robertson GS.
    J Pharmacol Exp Ther; 2006 Oct 15; 319(1):63-72. PubMed ID: 16809479
    [Abstract] [Full Text] [Related]

  • 25. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor.
    Aoki M, Fukunaga M, Sugimoto T, Hirano Y, Kobayashi M, Honda K, Yamada T.
    J Pharmacol Exp Ther; 2001 Sep 15; 298(3):1142-9. PubMed ID: 11504812
    [Abstract] [Full Text] [Related]

  • 26. Effect of cyclic AMP-elevating agents on airway ciliary beat frequency in central and lateral airways in rat precision-cut lung slices.
    Wohlsen A, Hirrle A, Tenor H, Marx D, Beume R.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):177-83. PubMed ID: 20303939
    [Abstract] [Full Text] [Related]

  • 27. The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis.
    Schmidt BM, Kusma M, Feuring M, Timmer WE, Neuhäuser M, Bethke T, Stuck BA, Hörmann K, Wehling M.
    J Allergy Clin Immunol; 2001 Oct 10; 108(4):530-6. PubMed ID: 11590377
    [Abstract] [Full Text] [Related]

  • 28. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.
    Karish SB, Gagnon JM.
    Ann Pharmacother; 2006 Jun 10; 40(6):1096-104. PubMed ID: 16735669
    [Abstract] [Full Text] [Related]

  • 29. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.
    Sanz MJ, Cortijo J, Morcillo EJ.
    Pharmacol Ther; 2005 Jun 10; 106(3):269-97. PubMed ID: 15922015
    [Abstract] [Full Text] [Related]

  • 30. PDE4 inhibitors: a review of current developments (2005 - 2009).
    Pagès L, Gavaldà A, Lehner MD.
    Expert Opin Ther Pat; 2009 Nov 10; 19(11):1501-19. PubMed ID: 19832118
    [Abstract] [Full Text] [Related]

  • 31. Electro-acupuncture attenuates stress-induced defecation in rats with chronic visceral hypersensitivity via serotonergic pathway.
    Tian XY, Bian ZX, Hu XG, Zhang XJ, Liu L, Zhang H.
    Brain Res; 2006 May 09; 1088(1):101-8. PubMed ID: 16650387
    [Abstract] [Full Text] [Related]

  • 32. Role of the serotonin3 receptor in stress-induced defecation.
    Miyata K, Kamato T, Nishida A, Ito H, Yuki H, Yamano M, Tsutsumi R, Katsuyama Y, Honda K.
    J Pharmacol Exp Ther; 1992 Apr 09; 261(1):297-303. PubMed ID: 1560375
    [Abstract] [Full Text] [Related]

  • 33. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
    Konrad FM, Bury A, Schick MA, Ngamsri KC, Reutershan J.
    PLoS One; 2015 Apr 09; 10(4):e0121725. PubMed ID: 25909327
    [Abstract] [Full Text] [Related]

  • 34. Relationship between phosphodiesterase type 4 inhibition and anti-inflammatory activity of CI-1044 in rat airways.
    Pruniaux MP, Lagente V, Ouaged M, Bertin B, Moreau F, Julien-Larose C, Rocher MN, Leportier C, Martin B, Bouget A, Dubuit JP, Burnouf C, Doherty AM, Bertrand CP.
    Fundam Clin Pharmacol; 2010 Feb 09; 24(1):73-82. PubMed ID: 19650853
    [Abstract] [Full Text] [Related]

  • 35. The inhibitory effect of melatonin on colonic motility disorders induced by water avoidance stress in rats.
    Tan W, Zhou W, Luo HS, Liang CB, Xia H.
    Eur Rev Med Pharmacol Sci; 2013 Nov 09; 17(22):3060-7. PubMed ID: 24302187
    [Abstract] [Full Text] [Related]

  • 36. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle.
    Halene TB, Siegel SJ.
    J Pharmacol Exp Ther; 2008 Jul 09; 326(1):230-9. PubMed ID: 18420599
    [Abstract] [Full Text] [Related]

  • 37. Impacts of peripheral obestatin on colonic motility and secretion in conscious fed rats.
    Chen CY, Chien EJ, Chang FY, Lu CL, Luo JC, Lee SD.
    Peptides; 2008 Sep 09; 29(9):1603-8. PubMed ID: 18565623
    [Abstract] [Full Text] [Related]

  • 38. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram.
    Zhao Y, Zhang HT, O'Donnell JM.
    J Pharmacol Exp Ther; 2003 May 09; 305(2):565-72. PubMed ID: 12704225
    [Abstract] [Full Text] [Related]

  • 39. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition.
    Oger S, Behr-Roussel D, Gorny D, Denys P, Lebret T, Alexandre L, Giuliano F.
    Eur Urol; 2007 Mar 09; 51(3):772-80; discussion 780-1. PubMed ID: 17097801
    [Abstract] [Full Text] [Related]

  • 40. Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain.
    Hirose R, Manabe H, Nonaka H, Yanagawa K, Akuta K, Sato S, Ohshima E, Ichimura M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):93-9. PubMed ID: 17658510
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.